SuperworthInternational Flavors & Fragrances IFF
- Market cap
- $24B
- PE
- 82.6×
- 10y median 35.5×
- Forward PE
- 27.3×
- 10y median 23.2×
- Price to sales
- 2.4×
- EV/EBIT
- 15.3×
- Revenue, 12 months
- $10B
- −5% on a year ago
- Net margin
- 2.9%
- Free cash flow yield
- 2.2%
International Flavors & Fragrances trades at 82.6× trailing earnings, pricier than 87% of the last ten years. Revenue was $10B over the last twelve months, down 5% on a year earlier with a 3% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.8B−8% | $2.7B−5% | $2.9B−4% | $2.9B−1% | $2.9B+4% | $2.8B+3% | $2.8B−2% | $1.9B−34% | $2.7B−8% | $2.6B−7% | $2.7B−4% | $2B+2% | |
| Cost of revenue | $1.9B−8% | $1.8B−7% | $1.9B−9% | $1.8B−9% | $1.9B−1% | $1.8B−3% | $1.8B−4% | $1.1B−40% | $1.7B−9% | $1.7B−5% | $1.7B−5% | $1.1B+1% |
| Gross profit | $924M−8% | $860M−1% | $1B+6% | $1.1B+15% | $1.1B+14% | $980M+14% | $1B+1% | $824M−23% | $983M−7% | $890M−9% | $1B−2% | $853M+4% |
| R&D | $157M+8% | $157M+10% | $166M+3% | $173M+8% | $162M+3% | $170M+8% | $164M−1% | $170M−2% | $174M+7% | $174M+2% | $166M+1% | $170M+0% |
| SG&A | $444M+8% | $444M+1% | $490M+8% | $493M+11% | $495M+12% | $517M+16% | $461M−6% | $409M−17% | $421M−15% | $469M−9% | $427M−7% | $437M+7% |
| $150M | −$2.5B | $199M+52% | $191M+32% | $249M+66% | $127M | −$903M | $142M−26% | $226M−9% | $97M−24% | $273M | $158M+11% | |
| Interest expense | $90M+8% | $89M−14% | $83M−17% | $79M−22% | $74M−18% | $69M−23% | $71M−15% | $61M−23% | $48M−35% | $49M−29% | $44M−38% | $46M−25% |
| Pre-tax income | $59M | −$2.6B+52720% | $115M+721% | $183M+266% | $95M+61% | −$115M−96% | −$994M | $438M+139% | $56M−41% | $22M | $209M | $64M−85% |
| $32M−80% | −$32M | $54M+146% | $11M−52% | $36M+13% | −$69M+116% | $23M−57% | −$112M | $15M−58% | −$9M−87% | $39M+70% | $31M | |
| Net income | $25M | −$2.6B+10340% | $60M | $170M+530% | $58M+132% | −$46M−98% | −$1B | $599M+252% | $40M−31% | $31M | $169M | $50M−92% |
| $0.10 | −$10.24+10140% | $0.23 | $0.66+500% | $0.23+130% | −$0.18−98% | −$3.98 | $2.33+253% | $0.16−30% | $0.12 | $0.66 | $0.20−91% | |
| 256M+0% | 255M+0% | 256M+0% | 256M+0% | 257M+0% | 256M+0% | 256M+0% | 257M+0% | 257M+0% | 256M+0% | 257M+0% | 257M+0% |
Gross profit: 22 periods, Q2 FY09 to Q3 FY14: not printed by the filing, worked out from its own lines.
Operating income: 22 periods, Q2 FY09 to Q3 FY14: not printed by the filing, worked out from its own lines.
EPS, diluted: Q4 FY09 and Q4 FY10: quarter's net income to common over its shares, to the cent, the shares from counts implied by EPS, near the year's EPS less the nine months'. 15 periods, Q4 FY11 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 12 periods, Q4 FY11 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. 3 periods, Q4 FY17 to Q4 FY23: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $1.9B | $1.9B to $1.9B | $0.81 | $0.64 to $1.00 | 9 |
| Q4 FY26 | $1.8B | $1.8B to $1.8B | $0.75 | $0.59 to $0.97 | 8 |
| Q1 FY27 | $2B | $1.9B to $2B | $0.94 | $0.92 to $0.96 | 3 |
| Q2 FY27 | $2B | $2B to $2B | $1.01 | $0.99 to $1.03 | 4 |
| Q3 FY27 | $2B | $1.9B to $2B | $1.05 | $1.03 to $1.08 | 3 |
| Q4 FY27 | $1.9B | $1.9B to $1.9B | $0.97 | $0.95 to $0.99 | 4 |
| Q1 FY28 | $2.1B | $2.1B to $2.1B | $1.26 | $1.23 to $1.29 | 4 |
| Q2 FY28 | $2.1B | $2B to $2.1B | $1.29 | $1.26 to $1.32 | 5 |
Peers
Companies in Chemicals - Specialty nearest International Flavors & Fragrances' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| IFFInternational Flavors & Fragrances | $24B | 82.6× | 35.5× | 27.3× | 2.4× | −5% | 2.9% |
| PPGPPG Industries | $24.6B | 15.8× | 24.0× | 13.4× | 1.5× | +5% | 9.6% |
| LYBLyondellBasell Industries | $21.5B | n/m | 9.2× | 9.2× | 0.7× | −2% | −1.1% |
| RPMRPM International | $12.6B | 18.3× | 25.5× | n/m | 1.6× | +6% | 8.7% |
| CLXClorox | $10.4B | 17.9× | 26.3× | n/m | 1.6× | −5% | 8.7% |
| APDAir Products and Chemicals | $68.4B | n/m | 28.1× | 21.6× | 5.4× | +5% | −0.4% |
| NEUNewmarket | $8B | 18.7× | 16.8× | n/m | 2.9× | −1% | 15.8% |
| AXTAAxalta Coating Systems | $7.3B | 21.1× | 28.3× | n/m | 1.4× | −1% | 6.8% |
| ECLEcolab | $80.9B | 38.7× | 37.3× | 33.5× | 4.8× | +7% | 12.6% |
| SHWSherwin-Williams | $81.8B | 31.1× | 33.3× | 26.3× | 3.4× | +6% | 11.0% |
| SXTSensient Technologies | $5.6B | 35.8× | 29.8× | n/m | 3.3× | +8% | 9.3% |
| Peer median | $17B | 19.9× | 27.2× | 21.6× | 2.3× | +5% | 9.0% |
Investors who own it
Investors we follow who held International Flavors & Fragrances at the end of Jun 30, 2026, from their 13F filings.
- Carl IcahnIcahn Capital4.1% of portfolio
More on International Flavors & Fragrances
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
Its groups
About
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .